통합검색
내가 찾은 검색어
'Immune checkpoint inhibitor' 에 대한 통합검색결과 131건입니다.
한빛사131건
-
Binary mineral nanoparticles enable intravascular delivery of metal ions to tumors for metalloimmunotherapy
- Nat. Commun. 12 January 2026 | https://doi.org/10.1038/s41467-025-68279-y
- 2026.01
- 의약학
-
Liver cancer chronically exposed to palmitate acquires ferroptosis resistance via the downregulation of glutamine-driven hepcidin expression
- Metab.-Clin. Exp. Dec 17 2025, S0026-0495(25)00339-7 | https://doi.org/10.1016/j.metabol.2025.156469
- 2025.12
- 의약학
-
Targeting cancer glutamine dependency with a first-in-class inhibitor of the mitochondrial glutamine transporter SLC1A5_var
- Nat. Commun. 03 November 2025;16, 9690(2025) | https://doi.org/10.1038/s41467-025-64730-2
- 2025.11
- 의약학
-
Open-label, single-arm, phase 2 trial to investigate the efficacy of sitravatinib plus tislelizumab combination as a second-line treatment for advance
- J. Hepatol. Nov 24 2025, S0168-8278(25)02626-1 | https://doi.org/10.1016/j.jhep.2025.10.032
- 2025.11
- 의약학
-
Artificial intelligence-powered spatial analysis of tumor microenvironment in patients with non-small cell lung cancer with acquired resistance to EGF
- J. Immunother. Cancer Oct 31 2025, 13 (10) e012374 | https://doi.org/10.1136/jitc-2025-012374
- 2025.10
- 의약학
-
4-1BB+ Tregs and inhibitory progenitor exhausted T cells confer resistance to anti-PD-L1 and anti-CTLA-4 combination therapy
- Cell Rep. Med. Oct 03 2025, S2666-3791(25)00481-1 | https://doi.org/10.1016/j.xcrm.2025.102408
- 2025.10
-
Dynamic modulation of claudin18.2 expression and remodeling of the tumor microenvironment in gastric cancer during chemo-immunotherapy
- J. Immunother. Cancer Sep 29 2025, 13 (9) e012683 | https://doi.org/10.1136/jitc-2025-012683
- 2025.09
- 의약학
-
Wnt inhibition alleviates resistance to anti-PD1 therapy and improves antitumor immunity in glioblastoma
- Proc. Natl. Acad. Sci. USA September 15, 2025 122 (38) e2414941122 | https://doi.org/10.1073/pnas.2414941122
- 2025.09
- 의약학
-
Pharmacological and structural characterization of vibostolimab, a novel anti-TIGIT blocking antibody for cancer immunotherapy
- J. Immunother. Cancer Aug 18 2025, 13 (8) e008972 | https://doi.org/10.1136/jitc-2024-008972
- 2025.08
-
Avidity-Based Capture of PD-L1-Expressing Exosomes via Dendrimer-Peptide Conjugates: A Nanoengineered Platform for Enhanced Prediction of Immunotherap
- Adv. Sci. Aug 21 2025, | https://doi.org/10.1002/advs.202509270
- 2025.08
- 의약학
-
Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohort
- J. Immunother. Cancer Jun 30 2025, 13 (6) e011760 | https://doi.org/10.1136/jitc-2025-011760
- 2025.06
- 의약학
-
Progressive accumulation of circulating CD27-CD28- effector/memory CD8+ T cells in patients with lung cancer blunts responses to immune checkpoint inh
- Exp. Mol. Med. May 01 2025, | https://doi.org/10.1038/s12276-025-01448-7
- 2025.05
- 의약학
-
Photoimmuno-Lure Nanoplatform for Enhancing T Cell Expansion in Glioblastoma via Synergistic Treatment of Photodynamic Therapy and Immune Checkpoint I
- Adv. Healthc. Mater. May 21 2025, | https://doi.org/10.1002/adhm.202500880
- 2025.05
- 바이오·의료융합
-
Single-cell RNA sequencing of baseline PBMCs predicts ICI efficacy and irAE severity in patients with NSCLC
- J. Immunother. Cancer May 22 2025, 13 (5) e011636 | https://doi.org/10.1136/jitc-2025-011636
- 2025.05
- 생명과학
-
Paradoxical Effect of Myosteatosis on the Immune Checkpoint Inhibitor Response in Metastatic Renal Cell Carcinoma
- J. Cachexia Sarcopenia Muscle Apr 2025, 16 (2) | https://doi.org/10.1002/jcsm.13758
- 2025.04
- 바이오·의료융합
-
Dendrimer Conjugates with PD-L1-Binding Peptides Enhance In Vivo Antitumor Immune Response
- Adv. Healthc. Mater. Apr 17 2025, | https://doi.org/10.1002/adhm.202500551
- 2025.04
- 의약학
-
DDX54 downregulation enhances anti-PD1 therapy in immune-desert lung tumors with high tumor mutational burden
- Proc. Natl. Acad. Sci. USA Apr 08 2025, 122 (14) | https://doi.org/10.1073/pnas.2412310122
- 2025.04
- 생명과학
-
Electric Pulse Regulated MXene Based Nanozymes for Integrative Bioelectricity Immuno-Cancer Therapy
- Adv. Funct. Mater. 03 April 2025 | https://doi.org/10.1002/adfm.202420870
- 2025.04
- 바이오·의료융합
-
Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6/Jak/Stat3 in PD-L1-high lung cancer
- J. Immunother. Cancer Mar 06 2025, 13 (3) e010612 | https://doi.org/10.1136/jitc-2024-010612
- 2025.03
- 의약학
-
Thermoresistant flagellin-adjuvanted cancer vaccine combined with photothermal therapy synergizes with anti-PD-1 treatment
- J. Immunother. Cancer Mar 21 2025, 13 (3) e010272 | https://doi.org/10.1136/jitc-2024-010272
- 2025.03
- 의약학
